Fig. 3

mvFD favors prognosis and response to chemotherapy in GBM patients. a, b Kaplan–Meier curves showing the differences of GBM patient survival based on mvFD value. c, d Kaplan–Meier curves showing the differences of GBM patient survival based on mvFD value and chemotherapy treatment. chemo+, patients received chemotherapy; chemo-, patients did not receive chemotherapy. a–d Log-rank test was used to obtain the P-value with the average value of mvFD in the GBM group used as the cut-off point to discriminate high (>1.06) and low (≤1.06) subgroups. The statistical difference is significant when P < 0.05. e–h Scatter plots and linear regression analyses showing the correlations between mvFD and progression-free survival (e, g) or overall survival (f, h) in GBM patients with chemotherapy (e, f) or without chemotherapy (g, h). The red straight line in each panel is the best fit line of linear regression. The red dotted lines in each panel are the 95% confidence band of the best fit line. The statistically significant linear regression is indicated when P < 0.05. r: correlation coefficient